These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 34800976)
1. On clinical trial fragility due to patients lost to follow up. Baer BR; Fremes SE; Gaudino M; Charlson M; Wells MT BMC Med Res Methodol; 2021 Nov; 21(1):254. PubMed ID: 34800976 [TBL] [Abstract][Full Text] [Related]
2. The fragility of statistically significant findings from randomized trials in spine surgery: a systematic survey. Evaniew N; Files C; Smith C; Bhandari M; Ghert M; Walsh M; Devereaux PJ; Guyatt G Spine J; 2015 Oct; 15(10):2188-97. PubMed ID: 26072464 [TBL] [Abstract][Full Text] [Related]
3. When the p Value Doesn't Cut It: The Fragility Index Applied to Randomized Controlled Trials in Colorectal Surgery. Nelms DW; Vargas HD; Bedi RS; Paruch JL Dis Colon Rectum; 2022 Feb; 65(2):276-283. PubMed ID: 34990426 [TBL] [Abstract][Full Text] [Related]
4. Bias and Loss to Follow-Up in Cardiovascular Randomized Trials: A Systematic Review. Fong LCW; Ford TJ; da Costa BR; Jüni P; Berry C J Am Heart Assoc; 2020 Jul; 9(14):e015361. PubMed ID: 32646264 [TBL] [Abstract][Full Text] [Related]
5. The Fragility Index in Hand Surgery Randomized Controlled Trials. Ruzbarsky JJ; Khormaee S; Daluiski A J Hand Surg Am; 2019 Aug; 44(8):698.e1-698.e7. PubMed ID: 30420197 [TBL] [Abstract][Full Text] [Related]
6. The Fragility of Statistically Significant Results in Pediatric Orthopaedic Randomized Controlled Trials as Quantified by the Fragility Index: A Systematic Review. Khormaee S; Choe J; Ruzbarsky JJ; Agarwal KN; Blanco JS; Doyle SM; Dodwell ER J Pediatr Orthop; 2018 Sep; 38(8):e418-e423. PubMed ID: 29979332 [TBL] [Abstract][Full Text] [Related]
7. The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index. Walsh M; Srinathan SK; McAuley DF; Mrkobrada M; Levine O; Ribic C; Molnar AO; Dattani ND; Burke A; Guyatt G; Thabane L; Walter SD; Pogue J; Devereaux PJ J Clin Epidemiol; 2014 Jun; 67(6):622-8. PubMed ID: 24508144 [TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
9. Fragility indices for only sufficiently likely modifications. Baer BR; Gaudino M; Charlson M; Fremes SE; Wells MT Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34848537 [TBL] [Abstract][Full Text] [Related]
10. The Statistical Fragility of Management Options for Acute Achilles Tendon Ruptures - A Systematic Review of Randomized Control Trial with Fragility Analysis. Doyle TR; Davey MS; Hurley ET J ISAKOS; 2022 Aug; 7(4):72-81. PubMed ID: 36189473 [TBL] [Abstract][Full Text] [Related]
12. The Fragility Index in a Cohort of Pediatric Randomized Controlled Trials. Matics TJ; Khan N; Jani P; Kane JM J Clin Med; 2017 Aug; 6(8):. PubMed ID: 28805717 [TBL] [Abstract][Full Text] [Related]
13. Lost to Follow-up and Withdrawal of Consent in Contemporary Global Cardiovascular Randomized Clinical Trials. Rodriguez F; Harrison RW; Wojdyla D; Mahaffey KW Crit Pathw Cardiol; 2015 Dec; 14(4):150-3. PubMed ID: 26569655 [TBL] [Abstract][Full Text] [Related]
14. The fragility index: how robust are the outcomes of head and neck cancer randomised, controlled trials? Suresh NV; Go BC; Fritz CG; Harris J; Ahluwalia V; Xu K; Lu J; Rajasekaran K J Laryngol Otol; 2024 Apr; 138(4):451-456. PubMed ID: 37795709 [TBL] [Abstract][Full Text] [Related]
15. [Anti-VEGF therapy of wet age-related macular degeneration: analysis of patients lost to follow-up]. Bobykin EV; Korotkih SA; Krokhalev VY; Buslaev RV; Beresneva NS; Morozova OV Vestn Oftalmol; 2021; 137(2):66-74. PubMed ID: 33881265 [TBL] [Abstract][Full Text] [Related]
16. Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial. Smith C; Jarvis C; Free C Trials; 2017 Dec; 18(1):577. PubMed ID: 29191231 [TBL] [Abstract][Full Text] [Related]
17. The Reproducibility of Cerebrovascular Randomized Controlled Trials. Adeeb N; Terrell DL; Whipple SG; Thakur JD; Griessenauer CJ; Adeeb A; Aslan A; Mamilly A; Mortazavi MM; Dossani RH; Guthikonda B; Ogilvy CS; Thomas AJ; Moore JM World Neurosurg; 2020 Aug; 140():e46-e52. PubMed ID: 32437984 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study. Fentie DT; Kassa GM; Tiruneh SA; Muche AA BMC Infect Dis; 2022 Sep; 22(1):727. PubMed ID: 36071386 [TBL] [Abstract][Full Text] [Related]
20. The Statistical Fragility of Platelet-Rich Plasma as Treatment for Chronic Noninsertional Achilles Tendinopathy: A Systematic Review and Meta-analysis. Xu AL; Ortiz-Babilonia C; Gupta A; Rogers D; Aiyer AA; Vulcano E Foot Ankle Orthop; 2022 Jul; 7(3):24730114221119758. PubMed ID: 36051864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]